Study IDs 2 cancer-promoting pathways in esophageal cancer
A non-traditional pathway for spiriting a cancer-promoting protein into the cell nucleus points to a possible combination therapy for esophageal cancer, researchers from The University of Texas MD Anderson Cancer Center reported in the latest issue of Cancer Cell. The mTOR molecular pathway promotes the activity of the Gli1 protein in esophageal cancer development and progression, they noted in the report (CC, March 20, 2012). The so-called “Hedgehog” pathway is

